부산대학교 도서관

Altieri B; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany; Bavarian Cancer Research Center (BZKF), University Hospital of Würzburg, Würzburg, Germany. Electronic address: Altieri_B@ukw.de.; Kircher S; Institute of Pathology, University of Würzburg, Würzburg, Germany.; Herterich S; Clinical Chemistry and Laboratory Medicine, University Hospital, University of Würzburg, Würzburg, Germany.; Jahn A; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany; National Center for Tumour Diseases (NCT), Dresden, Germany; European Reference Networks (ERN) GENTURIS, Hereditary Cancer Syndrome Center Dresden; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Teleanu MV; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Lippert J; Institute of Human Genetics, University of Würzburg, Würzburg, Germany.; Landwehr LS; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany.; Kimpel O; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany. Electronic address: https://twitter.com/EndoWue.; Reuter M; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany. Electronic address: https://twitter.com/EndoWue.; Remde H; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany. Electronic address: https://twitter.com/EndoWue.; Stenzinger A; Institute of Pathology, University Hospital of Heidelberg, Heidelberg, Germany.; Glimm H; European Reference Networks (ERN) GENTURIS, Hereditary Cancer Syndrome Center Dresden; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Translational Medical Oncology, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; Bargou RC; Bavarian Cancer Research Center (BZKF), University Hospital of Würzburg, Würzburg, Germany; Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Ronchi CL; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany; Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Appenzeller S; Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany.; Fassnacht M; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany; Clinical Chemistry and Laboratory Medicine, University Hospital, University of Würzburg, Würzburg, Germany; Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany; European Reference Networks (ERN) EURACAN, ERN for all Rare Adult Solid Cancers Expert Centre, Würzburg, Germany. Electronic address: https://twitter.com/EndoWue.; Kroiss M; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany; Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians-Universität München, Munich, Germany. Electronic address: Matthias.Kroiss@med.lmu.de.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Hanna Remde; Laura Schmidt-Pennington; Miriam Reuter; Laura-Sophie Landwehr; Marie Jensen; Harald Lahner; Otilia Kimpel; Barbara Altieri; Katharina Laubner; Jochen Schreiner; Joerg Bojunga; Stefan Kircher; Catarina Alisa Kunze; Anne Pohrt; Maria-Veronica Teleanu; Daniel Hübschmann; Albrecht Stenzinger; Hanno Glimm; Stefan Fröhling; Martin Fassnacht; Knut Mai; Matthias Kroiss

European Journal of Endocrinology. 188:485-493

William D; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; Bermúdez M; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Kübler A; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Kahlert C; Department for Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology Dresden, Dresden.; Distler M; Department for Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology Dresden, Dresden.; Weitz J; Department for Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology Dresden, Dresden.; Uhrig S; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Fröhlich M; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Hutter B; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Aust D; Institute of Pathology, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; Baretton G; Institute of Pathology, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; Wimberger P; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; Kast K; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; Meisel C; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; Gieldon L; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Porrmann J; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Wagner J; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Arlt M; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Franke M; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Fischer J; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Hackmann K; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Kreutzfeldt S; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg.; Institute of Human Genetics, Heidelberg University, Heidelberg.; Mock A; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg.; Institute of Human Genetics, Heidelberg University, Heidelberg.; Heilig CE; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg.; Institute of Human Genetics, Heidelberg University, Heidelberg.; Lipka DB; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg.; Institute of Human Genetics, Heidelberg University, Heidelberg.; Teleanu MV; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg.; Institute of Human Genetics, Heidelberg University, Heidelberg.; Schlenk RF; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg.; Institute of Human Genetics, Heidelberg University, Heidelberg.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg.; National Center of Tumor Diseases Trial Center, German Cancer Research Center and Heidelberg University Hospital, Heidelberg.; Brors B; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg.; Division of Applied Bioinformatics, DKFZ, Heidelberg.; Hübschmann D; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg.; Paramasivam N; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Richter D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; Center for Personalized Oncology, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; Beck K; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg.; Pfütze K; Sample Processing Laboratory, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg.; Buchhalter I; Omics IT and Data Management Core Facility, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg.; Weichert W; School of Medicine, Institute of Pathology, Technical University of Munich, Munich.; Herold T; Department of Medicine III, University Hospital, Ludwig Maximilians University Munich, Munich.; Department of Hematology, Oncology, and Stem-Cell Transplantation, Munich Hospital Bogenhausen, Munich Municipal Hospital Group, Munich, Germany.; Spiekermann K; Department of Medicine III, University Hospital, Ludwig Maximilians University Munich, Munich.; Jost PJ; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Keilholz U; Charité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg.; Klauschen F; Institute of Pathology, Ludwig Maximilian University of Munich, Munich.; BIFOLD-Berlin Institute for the Foundations of Learning and Data, Berlin.; Bauer S; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen.; DKTK, Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg.; Siveke JT; DKTK, Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg.; Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen.; Kindler T; University Cancer Center and Department of Internal Medicine III, University Medical Center Mainz, Mainz.; TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz.; DKTK, Partner Site Frankfurt/Mainz, a partnership between DKFZ and University Medical Center Mainz, Mainz.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.; German Cancer Consortium (DKTK), Partner Site Freiburg, a partnership between DKFZ and Medical Center-University of Freiburg, Freiburg.; Illert AL; Department of Internal Medicine I, Division of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg im Breisgau.; Department of Internal Medicine III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich.; Bitzer M; Department of Internal Medicine I, University Hospital Tübingen, Eberhard Karls University of Tübingen, Tübingen.; Schulze-Osthoff K; Department of Molecular Medicine, Interfaculty Institute for Biochemistry, Eberhard Karls University of Tübingen, Tübingen.; Schirmacher P; Institute of Pathology, Heidelberg University Hospital, Heidelberg.; Stenzinger A; Institute of Pathology, Heidelberg University Hospital, Heidelberg.; Horak P; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg.; Institute of Human Genetics, Heidelberg University, Heidelberg.; Heining C; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; Center for Personalized Oncology, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; Folprecht G; Department of Medicine I, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; Fröhling S; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg.; Institute of Human Genetics, Heidelberg University, Heidelberg.; Glimm H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; Center for Personalized Oncology, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; Schröck E; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; Jahn A; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden.; German Cancer Consortium (DKTK), Dresden.; German Cancer Research Center (DKFZ), Heidelberg.; Center for Personalized Oncology, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9919053637606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2949-8198 (Electronic) Linking ISSN: 29498198 NLM ISO Abbreviation: ESMO Gastrointest Oncol Subsets: PubMed not MEDLINE

Eisterer, W; Jiang, X; Christ, O; Glimm, H; Lee, K H; Pang, E; Lambie, K; Shaw, G; Holyoake, T. L; Petzer, A. L; Auewarakul, C; Barnett, M. J; Eaves, C. J; Eaves, A. C

Leukemia (08876924). Mar2005, Vol. 19 Issue 3, p435-441. 7p.

Möhrmann L; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, USA.; Werner M; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; Oleś M; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Knol L; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Arnold JS; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Mundt T; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Paramasivam N; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Richter D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Fröhlich M; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hutter B; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hüllein J; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Jahn A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Scheffold C; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Möhrmann EE; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Hanf D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Kreutzfeldt S; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heilig CE; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Teleanu MV; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Lipka DB; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Section of Translational Cancer Epigenomics, Department of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Beck K; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Molecular Precision Oncology Program, NCT Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Baude-Müller A; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Molecular Precision Oncology Program, NCT Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Jelas I; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Rieke DT; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Klotz LV; Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany.; Shah R; Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany.; Herold T; Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; Illert AL; Department of Internal Medicine I, Division of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg im Breisgau, Germany; Klinik und Poliklinik fur Innere Medizin III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.; Allgäuer M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Kerle IA; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Horak P; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heining C; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Schröck E; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Hübschmann D; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany; Innovation and Service Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Fröhling S; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Glimm H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Translational Functional Cancer Genomics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany. Electronic address: hanno.glimm@nct-dresden.de.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Herbst, F; Ball, C R; Zavidij, O; Fessler, S; Schmidt, M; Veelken, H; von Kalle, C; Glimm, H

Gene Therapy. Feb2011, Vol. 18 Issue 2, p210-212. 3p.

Maurus K; Institute of Pathology, University of Würzburg, Würzburg, Germany.; Kosnopfel C; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.; Kneitz H; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.; Appenzeller S; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.; Schrama D; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.; Glutsch V; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.; Roth S; Institute of Pathology, University of Würzburg, Würzburg, Germany.; Gerhard-Hartmann E; Institute of Pathology, University of Würzburg, Würzburg, Germany.; Rosenfeldt M; Institute of Pathology, University of Würzburg, Würzburg, Germany.; Möhrmann L; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), Dresden, Germany.; Faculty of Medicine, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany.; Fröhlich M; Computational Oncology Group, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hübschmann D; Computational Oncology Group, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Glimm H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany.; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Translational Functional Cancer Genomics, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Fröhling S; German Cancer Consortium (DKTK), Dresden, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Goebeler M; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.; Rosenwald A; Institute of Pathology, University of Würzburg, Würzburg, Germany.; Kutzner H; Dermatopathology, Friedrichshafen, Germany.; Schilling B; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Kordes, M; Röring, M; Heining, C; Braun, S; Hutter, B; Richter, D; Geörg, C; Scholl, C; Gröschel, S; Roth, W; Rosenwald, A; Geissinger, E; von Kalle, C; Jäger, D; Brors, B; Weichert, W; Grüllich, C; Glimm, H; Brummer, T; Fröhling, S

Leukemia. Apr 01, 2016 30(4):937-946

Westphal D; Department of Dermatology, University Hospital Carl Gustav Carus at Technische Universität (TU) Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Garzarolli M; Department of Dermatology, University Hospital Carl Gustav Carus at Technische Universität (TU) Dresden, Dresden, Germany.; Sergon M; Institute of Pathology, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; Horak P; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and DKFZ, Heidelberg, Germany.; Hutter B; German Cancer Consortium (DKTK), Heidelberg, Germany.; Computational Oncology, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.; Becker JC; Department of Dermatology, University Hospital Essen, Essen, Germany.; Translational Skin Cancer Research, DKTK, Partner Site Essen, Essen, Germany.; Wiegel M; Department of Dermatology, University Hospital Carl Gustav Carus at Technische Universität (TU) Dresden, Dresden, Germany.; Maczey E; Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany.; Blum S; Institute and Policlinic of Diagnostic and Interventional Radiology, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; Grosche-Schlee S; Clinic and Policlinic of Nuclear Medicine, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; Rütten A; Dermatopathology Friedrichshafen, Friedrichshafen, Germany.; Ugurel S; Department of Dermatology, University Hospital Essen, Essen, Germany.; Stenzinger A; German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Glimm H; Translational Functional Cancer Genomics, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Department of Translational Medical Oncology NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; DKTK, Dresden, Germany.; Aust D; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Institute of Pathology, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; Tumor and Normal Tissue Bank of the UCC/NCT Site Dresden, NCT Dresden and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; Baretton G; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Institute of Pathology, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; Tumor and Normal Tissue Bank of the UCC/NCT Site Dresden, NCT Dresden and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; Beissert S; Department of Dermatology, University Hospital Carl Gustav Carus at Technische Universität (TU) Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Fröhling S; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and DKFZ, Heidelberg, Germany.; Redler S; Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Surowy H; Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Meier F; Department of Dermatology, University Hospital Carl Gustav Carus at Technische Universität (TU) Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Skin Cancer Center at the University Cancer Center Dresden, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Herbst, F; Ball, C R; Zavidij, O; Fessler, S; Schmidt, M; Veelken, H; von Kalle, C; Glimm, H

Gene Therapy. Feb 01, 2011 18(2):210-212

Fan, F; Bashari, M H; Morelli, E; Tonon, G; Malvestiti, S; Vallet, S; Jarahian, M; Seckinger, A; Hose, D; Bakiri, L; Sun, C; Hu, Y; Ball, C R; Glimm, H; Sattler, M; Goldschmidt, H; Wagner, E F; Tassone, P; Jaeger, D; Podar, K

Leukemia. July, 2017, Vol. 31 Issue 7, p1570.

Illert AL; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Medicine III, Faculty of Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.; Center for Personalized Medicine (ZPM), Freiburg, Germany.; Center for Personalized Medicine (ZPM), Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site TU Munich, Munich, Germany.; Stenzinger A; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Bitzer M; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; Center for Personalized Medicine (ZPM), Tübingen, Germany.; Horak P; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Gaidzik VI; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Center for Personalized Medicine (ZPM), Ulm, Germany.; Möller Y; Center for Personalized Medicine (ZPM), Tübingen, Germany.; M3 Research Institute University Hospital Tübingen, Tübingen, Germany.; Beha J; Center for Personalized Medicine (ZPM), Tübingen, Germany.; Öner Ö; Center for Personalized Medicine (ZPM), Tübingen, Germany.; Schmitt F; Center for Personalized Medicine (ZPM), Tübingen, Germany.; Laßmann S; Center for Personalized Medicine (ZPM), Freiburg, Germany.; Institute for Surgical Pathology, Medical Center, University of Freiburg, Freiburg, Germany.; Ossowski S; Center for Personalized Medicine (ZPM), Tübingen, Germany.; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.; Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen, Germany.; Schaaf CP; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Hallek M; Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for integrated Oncology (CIO-ABCD), Aachen-Bonn-Cologne-Düsseldorf, Germany.; Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.; Center for integrated Oncology (CIO-ABCD), Aachen-Bonn-Cologne-Düsseldorf, Germany.; Albers P; Department of Urology, Heinrich-Heine University, Medical Faculty, Düsseldorf, Germany.; Center for integrated Oncology (CIO-ABCD), Aachen-Bonn-Cologne-Düsseldorf, Germany.; Fehm T; Department of Gynecology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Center for integrated Oncology (CIO-ABCD), Aachen-Bonn-Cologne-Düsseldorf, Germany.; Brossart P; Department of Oncology, Hematology, Stem Cell Transplantation, Cell- and Immunotherapies, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.; Center for integrated Oncology (CIO-ABCD), Aachen-Bonn-Cologne-Düsseldorf, Germany.; Glimm H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Schadendorf D; Department of Dermatology, University Duisburg-Essen, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK) Partner Site, Essen, Germany.; National Center for Tumor Diseases (NCT), NCT-West, Campus Essen, Essen, Germany.; Westdeutsches Tumorzentrum (WTZ), Essen, Germany.; Research Alliance Ruhr - Research Center One Health, University Duisburg-Essen, Essen, Germany.; Bleckmann A; Department of Medicine A: Hematology, Oncology, and Pneumology, University Hospital Münster (UKM), Münster, Germany.; West German Cancer Center, University Hospital Münster, Münster, Germany.; Brandts CH; University Cancer Center (UCT) Frankfurt-Marburg, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK) Partner Site, Frankfurt, Germany.; Esposito I; Institute of Pathology, Heinrich-Heine University and University Hospital, Düsseldorf, Germany.; Center for Personalized Medicine (ZPM), Düsseldorf, Germany.; Mack E; Department of Hematology, Oncology and Immunology, University Hospital Marburg and Philipps-University, Marburg, Germany.; Peters C; Institute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany.; Bokemeyer C; Department of Oncology, Hematology and BMT with section of Pneumology, University of Hamburg, Hamburg, Germany.; Fröhling S; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Kindler T; University Cancer Center, University Medical Center Mainz, Johannes Gutenberg-University, Mainz, Germany.; German Cancer Consortium (DKTK) Partner Site Mainz, Mainz, Germany.; Algül H; Institute for Tumor Metabolism, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.; Comprehensive Cancer Center Munich TUM, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.; Heinemann V; Comprehensive Cancer Center Munich, Klinikum Großhadern, Ludwig Maximilian University of Munich, Munich, Germany.; Department of Medicine III, Klinikum Großhadern, Ludwig Maximilian University of Munich, Munich, Germany.; Döhner H; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.; Bargou R; Comprehensive Cancer Center Mainfranken, Uniklinikum Würzburg, Würzburg, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site Würzburg, Würzburg, Germany.; Ellenrieder V; Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.; Hillemanns P; Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany.; Lordick F; Comprehensive Cancer Center Central Germany and University Cancer Center Leipzig,, University Medicine Leipzig, Leipzig, Germany.; Hochhaus A; Comprehensive Cancer Center Central Germany and Department of Hematology and Internal Oncology, Universitätsklinikum Jena, Jena, Germany.; Beckmann MW; University Hospital Erlangen, Department of Obstetrics and Gynecology, Friedrich-Alexander-Universität Erlangen, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nuremberg, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site Erlangen, Erlangen, Germany.; Pukrop T; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.; Comprehensive Cancer Center Ostbayern, Regensburg, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site Regensburg, Regensburg, Germany.; Trepel M; Department of Hematology and Medical Oncology, Augsburg University Hospital, Augsburg, Germany.; Comprehensive Cancer Center Augsburg, CCC Alliance WERA, Augsburg, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site Augsburg, Augsburg, Germany.; Sundmacher L; Department of Health Services Management, Ludwig-Maximilians-Universität, Munich, Germany.; Wesselmann S; Deutsche Krebsgesellschaft (DKG), Berlin, Germany.; Nettekoven G; Deutsche Krebshilfe, Bonn, Germany.; Kohlhuber F; Deutsche Krebshilfe, Bonn, Germany.; Heinze O; Department Medical Information Systems, University Hospital Heidelberg, Heidelberg, Germany.; Budczies J; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Werner M; Center for Personalized Medicine (ZPM), Freiburg, Germany.; Institute for Surgical Pathology, Medical Center, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany.; Nikolaou K; Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany.; Beer AJ; Department of Nuclear Medicine, Ulm University Hospital, Ulm, Germany.; Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, University Hospital Tübingen, Tübingen, Germany.; Comprehensive Cancer Center Tübingen-Stuttgart, Stuttgart, Germany.; Weichert W; Center for Personalized Medicine (ZPM), Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute of Pathology, Technische Universität München, Munich, Germany.; German Cancer Consortium (DKTK) Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site TU Munich, Munich, Germany.; Keilholz U; Charité Comprehensive Cancer Center, Charité, Berlin, Germany.; Boerries M; Center for Personalized Medicine (ZPM), Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Freiburg, Germany.; Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany.; Kohlbacher O; Center for Personalized Medicine (ZPM), Tübingen, Germany.; Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen, Germany.; Institute for Translational Bioinformatics, University Medical Center, Tübingen, Germany.; Department of Computer Science, Applied Bioinformatics, University of Tübingen, Tübingen, Germany.; Duyster J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Personalized Medicine (ZPM), Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany.; Thimme R; Center for Personalized Medicine (ZPM), Freiburg, Germany.; Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany.; Department of Medicine II, Freiburg, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Seufferlein T; Center for Personalized Medicine (ZPM), Ulm, Germany.; Department of Internal Medicine I, University Hospital, University of Ulm, Ulm, Germany.; Schirmacher P; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Malek NP; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany. nisar.malek@med.uni-tuebingen.de.; Center for Personalized Medicine (ZPM), Tübingen, Germany. nisar.malek@med.uni-tuebingen.de.; M3 Research Institute University Hospital Tübingen, Tübingen, Germany. nisar.malek@med.uni-tuebingen.de.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

von Kalle, Christof; Glimm, Hanno; Schulz, Gregor; Mertelsmann, Roland; Henschler, Reinhard; von Kalle, C; Glimm, H; Schulz, G; Mertelsmann, R; Henschler, R

Current Opinion in Hematology; Jan1998, Vol. 5 Issue 1, p79-86, 8p

Blaes, J; Weiler, M; Sahm, F; Hentschel, B; Osswald, M; Czabanka, M; Thomé, C M; Schliesser, M G; Pusch, S; Luger, S; Winkler, F; Radbruch, A; Jugold, M; Simon, M; Steinbach, J P; Schackert, G; Tatagiba, M; Westphal, M; Tonn, J C; Gramatzki, D; Pietsch, T; Hartmann, C; Glimm, H; Vajkoczy, P; von Deimling, A; Platten, M; Weller, M; Wick, W

Journal of Neuro-Oncology. 117:25-32

Gabriel R; Eckenberg R; Paruzynski A; Bartholomae CC; Nowrouzi A; Arens A; Howe SJ; RECCHIA, Alessandra; Cattoglio C; Wang W; Faber K; Schwarzwaelder K; Kirsten R; Deichmann A; Ball CR; Balaggan KS; Yáñez Muñoz RJ; Ali RR; Gaspar HB; Biasco L; Aiuti A; Cesana D; Montini E; Naldini L; Cohen Haguenauer O; MAVILIO, Fulvio; Thrasher AJ; Glimm H; von Kalle C; Saurin W; Schmidt M.

Nature Medicine. 15:1431-1436

Jahn A; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; German Cancer Consortium (DKTK) Dresden, Germany; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Rump A; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; German Cancer Consortium (DKTK) Dresden, Germany; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Widmann TJ; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; German Cancer Consortium (DKTK) Dresden, Germany; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Heining C; German Cancer Consortium (DKTK) Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Horak P; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Hutter B; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.; Paramasivam N; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.; Gieldon L; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.; Drukewitz S; German Cancer Consortium (DKTK) Dresden, Germany; Core Unit for Molecular Tumor Diagnostics, NCT Dresden and DKFZ, Dresden, Germany.; Kübler A; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Bermudez M; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Hackmann K; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Porrmann J; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Wagner J; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Arlt M; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Franke M; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Fischer J; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Kowalzyk Z; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; William D; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; German Cancer Consortium (DKTK) Dresden, Germany; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Core Unit for Molecular Tumor Diagnostics, NCT Dresden and DKFZ, Dresden, Germany.; Weth V; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany.; Oster S; German Cancer Consortium (DKTK) Dresden, Germany; Core Unit for Molecular Tumor Diagnostics, NCT Dresden and DKFZ, Dresden, Germany.; Fröhlich M; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.; Hüllein J; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.; Valle González C; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany; University of Seville, Seville, Spain.; Kreutzfeldt S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Mock A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; Heilig CE; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Lipka DB; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Möhrmann L; German Cancer Consortium (DKTK) Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Hanf D; German Cancer Consortium (DKTK) Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Oleś M; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Teleanu V; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; Allgäuer M; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Ruhnke L; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Kutz O; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany.; Knurr A; Department of Medical Informatics for Translational Oncology, DKFZ, Heidelberg, Germany.; Laßmann A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Endris V; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Neumann O; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Penzel R; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Beck K; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Richter D; German Cancer Consortium (DKTK) Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Winter U; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Wolf S; German Cancer Consortium (DKTK), Heidelberg, Germany; High-Throughput Sequencing Unit, Genomics and Proteomics Core Facility, DKFZ, Heidelberg, Germany.; Pfütze K; German Cancer Consortium (DKTK), Heidelberg, Germany; Sample Processing Laboratory, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Geörg C; German Cancer Consortium (DKTK), Heidelberg, Germany; Sample Processing Laboratory, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Meißburger B; German Cancer Consortium (DKTK), Heidelberg, Germany; Sample Processing Laboratory, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Buchhalter I; Omics IT and Data Management Core Facility, DKFZ, Heidelberg, Germany.; Augustin M; Department of Hematology and Oncology, Klinikum Nuremberg, Paracelsus Medical University, Nuremberg, Germany.; Aulitzky WE; Department of Hematology, Oncology and Palliative Medicine, Robert Bosch Hospital, Stuttgart, Germany.; Hohenberger P; Sarcoma Unit, Interdisciplinary Tumor Center Mannheim, Mannheim University Medical Center, Heidelberg University, Mannheim, Germany; Division of Surgical Oncology and Thoracic Surgery, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Kroiss M; Department of Medicine I, Würzburg University Hospital, Würzburg, Germany; Comprehensive Cancer Mainfranken, University of Würzburg, Würzburg, Germany; Department of Medicine IV, University Hospital, Ludwig Maximilians University Munich, Munich, Germany.; Schirmacher P; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Schlenk RF; German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany; NCT Trial Center, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Berlin, Germany; DKTK, Berlin, Germany.; Klauschen F; DKTK, Berlin, Germany; Institute of Pathology, Charité - Universitätsmedizin Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Folprecht G; German Cancer Consortium (DKTK) Dresden, Germany; Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Bauer S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany; DKTK, Essen, Germany.; Siveke JT; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany; DKTK, Essen, Germany; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany; Division of Solid Tumor Translational Oncology, DKTK, Essen, and DKFZ, Heidelberg, Germany.; Brandts CH; University Cancer Center (UCT) Frankfurt, University Hospital Frankfurt, Goethe University, Frankfurt, Germany; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; DKTK, Frankfurt, Germany.; Kindler T; UCT Mainz, Johannes Gutenberg University Mainz, Mainz, Germany; Department of Hematology, Medical Oncology and Pneumology, University Medical Center, Mainz, Germany; DKTK, Mainz, Germany.; Boerries M; Comprehensive Cancer Center Freiburg, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Institute of Medical Bioinformatics and Systems Medicine, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; DKTK, Freiburg, Germany.; Illert AL; Comprehensive Cancer Center Freiburg, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; DKTK, Freiburg, Germany; Department of Internal Medicine I, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; von Bubnoff N; DKTK, Freiburg, Germany; Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany.; Jost PJ; Department of Hematology and Oncology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany; Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria; DKTK, Munich, Germany.; Metzeler KH; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Bitzer M; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany; DKTK, Tübingen, Germany.; Schulze-Osthoff K; DKTK, Tübingen, Germany; Department of Molecular Medicine, Interfaculty Institute for Biochemistry, University of Tübingen, Tübingen, Germany.; von Kalle C; Clinical Study Center, Charité - Universitätsmedizin Berlin, and Berlin Institute of Health, Berlin, Germany.; Brors B; German Cancer Consortium (DKTK), Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.; Stenzinger A; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Weichert W; DKTK, Munich, Germany; Institute of Pathology, Technical University Munich, Munich, Germany.; Hübschmann D; German Cancer Consortium (DKTK), Heidelberg, Germany; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Heidelberg, Germany.; Fröhling S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Glimm H; German Cancer Consortium (DKTK) Dresden, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Schröck E; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; German Cancer Consortium (DKTK) Dresden, Germany; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Core Unit for Molecular Tumor Diagnostics, NCT Dresden and DKFZ, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany. Electronic address: Evelin.Schroeck@uniklinikum-dresden.de.; Klink B; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany, ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; German Cancer Consortium (DKTK) Dresden, Germany; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Center for Personalized Oncology, National Center for Tumor Diseases (NCT) Dresden and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Core Unit for Molecular Tumor Diagnostics, NCT Dresden and DKFZ, Dresden, Germany; National Center of Genetics (NCG), Laboratoire National de Santé (LNS), Dudelange, Luxembourg; Department of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Deichmann, A; Hacein-Bey-Abina, S; Schmidt, M; Garrigue, A; Brugman, MH (Martijn); Hu, J; Glimm, H; Gyapay, G; Prum, B; Fraser, CC; Fischer, N; Schwarzwaelder, K; Siegler, ML; de Ridder, D (Dirk); Overzet, Karin; Howe, SJ; Thrasher, AJ; Wagemaker, Gerard; Abel, U; Staal, Frank; Delabesse, E; Villeval, JL; Aronow, B; Hue, C; Prinz, C; Wissler, M; Klanke, C; Weissenbach, J; Alexander, I; Fischer, A; von Kalle, C; Cavazzana-Calvo, M

Journal of Clinical Investigation. 117:2225-2232

Ott, MG; Schmidt, M; Schwarzwaelder, K; Stein, S; Siler, U; Koehl, U; Glimm, H; Kühlcke, K; Schilz, A; Kunkel, H

NATURE MEDICINE. 12(4):401-409

Peters, C.E; Clarke, E; Glimm, H; Lansdorp, P.M; C.J.Eaves; Thomas, T.E

Experimental Hematology. 28(7):48-48

Glimm, H; Eisterer, W; Lee, K; Cashman, J; Holyoake, T L; Nicolini, F; Shultz, L D; von, Kalle C; Eaves, C J

Journal of Clinical Investigation. 107:199-206